Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Animal healthcare focuses on effective animal health management by diagnosing and treating the diseases. Outbreak of animal diseases restrict trading of animal origin products and increases cost of disease management and also hampers the global economy.

The Europe animal healthcare market size is estimated to be valued at US$ 13,119.7 million in 2020 and is expected to exhibit a CAGR of 4.5% over the forecast period (2020-2027).

Figure 1. Europe Animal Healthcare Market Value (US$ Mn), by Country, 2020

Europe Animal Healthcare  | Coherent Market Insights

Increasing incidence of zoonotic viral pathogens and increasing expansion strategies adopted by manufacturers are factors propelling growth of the Europe animal healthcare market

Increasing product launches and strategic collaborations between manufacturers and regional authorities to address increasing demand for animal healthcare is contributing to the market growth. According to the Animal Disease Notification System (ADNS), 2018, in Bulgaria, around 14 outbreak of A(H5N8) viruses and highly pathogenic avian influenza (HPAI) in poultry was reported from August 2018 to November 2018. To address the increasing prevalence of these zoonotic diseases, regional governments are focused on improving animal health by collaborating with manufacturers to promote research & development of new drug treatments.

Moreover, strategies adopted by manufacturers to expand their product portfolio and market presence is expected to propel growth of the market over the forecast period. For instance, in July 2019, Ceva Santé Animale acquired IDT Biologika GmbH’s veterinary biopharmaceutical portfolio, which is expected to strengthen Ceva’s product offerings.

request-sample

Europe Animal Healthcare Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 13,119.7 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 4.5% 2027 Value Projection: US$ 17,837.8 Mn
Geographies covered:
  • Europe: Germany, U.K., Spain, France, Italy, Russia, Switzerland, Netherlands, and Rest of Europe
Segments covered:
  • By Animal Type:
    • Livestock: Bovine, Porcine, Poultry, Other.
    • Companion: Canine, Feline, Equine.
  • By Route of Administration: Oral, Topical.
    • Injectable: Subcutaneous Injections, Intramuscular Injections, Intravenous Injections, Intra-peritoneal Injections, Others.
  • By Indication: Infectious Diseases, Pain, Auto-immune Disease, Others.
Companies covered:

Merck & Co., Inc., Virbac, Dechra Pharmaceuticals Plc., Vetoquinol S.A., Zoetis Inc., Ceva Santé Animale, Bayer AG, Elanco, Evonik Industries AG, and Archer Daniels Midland Company

Growth Drivers:
  • Increasing incidence of zoonotic viral pathogens
  • Increasing demand for protein from animal source
  • Increasing government initiatives to provide improved animal healthcare
Restraints & Challenges:
  • Stringent regulations for sales and usage of antibiotics
  • High cost of animal healthcare services

Moreover, increasing implementation of regulatory guidelines by regional and local authorities in Europe for overall improvement of animal healthcare is expected to drive the market growth over the forecast period. For instance, in 2018, the European Medicine Agency initiated multi-stakeholder workshop for providing guidelines on veterinary regulatory science and offered proposals for development of veterinary medicine.

Figure 2. Europe Animal Healthcare Market Share (%), by Indication, 2020

Europe Animal Healthcare  | Coherent Market Insights

Increasing in the animal farming is expected to drive the market growth over the forecast period

The significant increase in animal farming in Europe has led to a rise in demand for efficient animal health services in order to improve food safety. According to the U.S. Department of Agricultural (USDA) report published in 2018, Lithuania is the largest poultry meat producer among the Baltic States in Europe, and production of chicken meat in Lithuania was around 110,700 MT in 2015, which was an increase of 11% from 2014.

Increasing number of regulations for animal vaccinations have led to high adoption of animal health products, which is expected to drive the market growth over the forecast period. For instance, the European Commission for the control of foot-and-mouth disease (EuFMD), and the Food and Agriculture Organization developed a progressive control pathway for managing foot-and-mouth disease (FMD).

Europe Animal Healthcare Market Restraints

However, stringent regulations on sales and usage of antibiotics, and high cost of animal healthcare services are expected to hamper growth of the Europe animal healthcare market. For instance, in 2017, the HealthforAnimals Association launched Antibiotics Commitment, a program associated with antimicrobial resistance (AMR), which promotes responsible use of antibiotics. Such awareness programs and stringent regulations have led to a decline in sales of antimicrobial agents used for veterinary treatment. According to the European Medicines Agency (EMA) report published in October 2018, there was 20% decrease in the overall sales of veterinary antimicrobials across Europe between 2011 and 2016.

Europe Animal Healthcare Market – Impact of Coronavirus (Covid-19) Pandemic

COVID-19 has had a significant impact on the livestock sector. The actions taken in many countries across the world to stop the spread of the coronavirus such as travel restrictions, nationwide lockdowns, and border controls have led to the following consequences:

  • Difficulty in transporting live animals and animal products such as milk, meat, and eggs
  • Restrictions and limitations on seasonal border crossings with ruminants
  • Restricted capacity to purchase necessary production inputs
  • Restricted access to labor and professional services

Such factors have led to a decrease in sales and processing capacity of animal products, and a slowdown of the market growth.

Key Players

Major players operating in the Europe animal healthcare market include Merck & Co., Inc., Virbac, Dechra Pharmaceuticals Plc., Vetoquinol S.A., Zoetis Inc., Ceva Santé Animale, Bayer AG, Elanco, Evonik Industries AG, and Archer Daniels Midland Company.

Animal healthcare include veterinary and over-the-counter drugs, supplements, nutraceuticals, vaccines, antibiotics and parasiticides, which are used in the treatment of disease associated with digestive system, immunological system, reproductive system, respiratory, and urinary system of animals. Rapid increase in zoonotic viral diseases and other animal-borne diseases can have adverse effects on farming and other occupation. Efficient animal healthcare can facilitate enhanced productivity of livestock to the farmers, as livestock animals provide major protein source through meat and milk. Increasing public-private collaboration to increase awareness about efficient animal healthcare in Europe is expected to drive growth of the Europe animal healthcare market.

Market Dynamics

Market players are focused on investments in research and development activities in order to strengthen their market presence in Europe, and to develop novel products to prevent diseases in livestock and pets. For instance, in May 2019, Boehringer Ingelheim collaborated with the Veterinary Oncology Advisory Board (VOAB) comprising experts in veterinary oncology from the U.S., Europe, and Japan to develop therapeutic veterinary solutions. Moreover, in 2018, Boehringer Ingelheim invested US$ 220 million for the development of a production center for veterinary public health in French Rhône-Alpes region, also known as the European vaccine valley.

Companies and their subsidiaries operating in Europe region intend to leverage their proprietary technologies for the development of novel therapeutics to treat serious medical conditions in animals. For instance, in April 2019, Interporc, a Spain-based pork board unveiled a new certified animal welfare seal, IAWS, to endorse good practices that will increase demand for animal healthcare, and drive the market growth.

Key features of the study:

  • This report provides in-depth analysis of the Europe animal healthcare market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the Europe animal healthcare market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Merck & Co., Inc., Virbac, Dechra Pharmaceuticals Plc, Vetoquinol S.A., Zoetis Inc., Ceva Santé Animale, Bayer AG, Elanco, Evonik Industries AG, and Archer Daniels Midland Company
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future drug launches, drug class up-gradation, market expansion, and marketing tactics
  • The Europe animal healthcare market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Europe animal healthcare market

Detailed Segmentation:

  • Europe Animal Healthcare Market, By Animal Type:
    • Herbal Extracts
    • Livestock Animals
      • Bovine
      • Porcine
      • Poultry
      • Others
    • Companion Animals
      • Canine
      • Feline
      • Equine
  • Europe Animal Healthcare Market, By Route of Administration:
    • Memory Enhancement
    • Oral
    • Topical
    • Injectable
      • Subcutaneous Injections
      • Intramuscular Injections
      • Intravenous Injections
      • Intra-peritoneal Injections
      • Others
  • Europe Animal Healthcare Market, By Indication:
    • Infectious Disease
    • Pain
    • Autoimmune Disease
    • Others 
  • Europe Animal Healthcare Market, By Country:
    • U.K.
      • By Animal Type:
        • Livestock Animals
          • Bovine
          • Porcine
          • Poultry
          • Others
        • Companion Animals
          • Canine
          • Feline
          • Equine
      • By Route of Administration:
        • Oral
        • Topical
        • Injectable
          • Subcutaneous Injections
          • Intramuscular Injections
          • Intravenous Injections
          • Intra-peritoneal Injections
          • Others
      • By Indication:
        • Infectious Disease
        • Pain
        • Autoimmune Disease
        • Others 
    • Germany
      • By Animal Type:
        • Livestock Animals
          • Bovine
          • Porcine
          • Poultry
          • Others
        • Companion Animals
          • Canine
          • Feline
          • Equine
      • By Route of Administration:
        • Oral
        • Topical
        • Injectable
          • Subcutaneous Injections
          • Intramuscular Injections
          • Intravenous Injections
          • Intra-peritoneal Injections
          • Others
      • By Indication:
        • Infectious Disease
        • Pain
        • Autoimmune Disease
        • Others 
    • France
      • By Animal Type:
        • Livestock Animals
          • Bovine
          • Porcine
          • Poultry
          • Others
        • Companion Animals
          • Canine
          • Feline
          • Equine
      • By Route of Administration:
        • Oral
        • Topical
        • Injectable
          • Subcutaneous Injections
          • Intramuscular Injections
          • Intravenous Injections
          • Intra-peritoneal Injections
          • Others
      • By Indication:
        • Infectious Disease
        • Pain
        • Autoimmune Disease
        • Others 
    • Spain
      • By Animal Type:
        • Livestock Animals
          • Bovine
          • Porcine
          • Poultry
          • Others
        • Companion Animals
          • Canine
          • Feline
          • Equine
      • By Route of Administration:
        • Oral
        • Topical
        • Injectable
          • Subcutaneous Injections
          • Intramuscular Injections
          • Intravenous Injections
          • Intra-peritoneal Injections
          • Others
      • By Indication:
        • Infectious Disease
        • Pain
        • Autoimmune Disease
        • Others 
    • Russia
      • By Animal Type:
        • Livestock Animals
          • Bovine
          • Porcine
          • Poultry
          • Others
        • Companion Animals
          • Canine
          • Feline
          • Equine
      • By Route of Administration:
        • Oral
        • Topical
        • Injectable
          • Subcutaneous Injections
          • Intramuscular Injections
          • Intravenous Injections
          • Intra-peritoneal Injections
          • Others
      • By Indication:
        • Infectious Disease
        • Pain
        • Autoimmune Disease
        • Others 
    • Switzerland
      • By Animal Type:
        • Livestock Animals
          • Bovine
          • Porcine
          • Poultry
          • Others
        • Companion Animals
          • Canine
          • Feline
          • Equine
      • By Route of Administration:
        • Oral
        • Topical
        • Injectable
          • Subcutaneous Injections
          • Intramuscular Injections
          • Intravenous Injections
          • Intra-peritoneal Injections
          • Others
      • By Indication:
        • Infectious Disease
        • Pain
        • Autoimmune Disease
        • Others 
    • Netherlands
      • By Animal Type:
        • Livestock Animals
          • Bovine
          • Porcine
          • Poultry
          • Others
        • Companion Animals
          • Canine
          • Feline
          • Equine
      • By Route of Administration:
        • Oral
        • Topical
        • Injectable
          • Subcutaneous Injections
          • Intramuscular Injections
          • Intravenous Injections
          • Intra-peritoneal Injections
          • Others
      • By Indication:
        • Infectious Disease
        • Pain
        • Autoimmune Disease
        • Others 
    • Italy
      • By Animal Type:
        • Livestock Animals
          • Bovine
          • Porcine
          • Poultry
          • Others
        • Companion Animals
          • Canine
          • Feline
          • Equine
      • By Route of Administration:
        • Oral
        • Topical
        • Injectable
          • Subcutaneous Injections
          • Intramuscular Injections
          • Intravenous Injections
          • Intra-peritoneal Injections
          • Others
      • By Indication:
        • Infectious Disease
        • Pain
        • Autoimmune Disease
        • Others 
    • Rest of Europe
      • By Animal Type:
        • Livestock Animals
          • Bovine
          • Porcine
          • Poultry
          • Others
        • Companion Animals
          • Canine
          • Feline
          • Equine
      • By Route of Administration:
        • Oral
        • Topical
        • Injectable
          • Subcutaneous Injections
          • Intramuscular Injections
          • Intravenous Injections
          • Intra-peritoneal Injections
          • Others
      • By Indication:
        • Infectious Disease
        • Pain
        • Autoimmune Disease
        • Others 
  • Company Profiles
    • Merck & Co., Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Virbac
    • Dechra Pharmaceuticals Plc
    • Vetoquinol S.A.
    • Zoetis Inc.
    • Ceva Santé Animale
    • Bayer AG
    • Elanco
    • Evonik Industries AG
    • Archer Daniels Midland Company

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Animal Type
      • Market Snippet, By Route of Administration
      • Market Snippet, By Indication
      • Market Snippet, By Country
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market trends
    • Partnership, Agreement, and Collaboration Scenario
    • Product Launches and Approvals
    • Regulatory Scenario
    • PEST Analysis
  4. Europe Animal Healthcare Market – Impact of Coronavirus (Covid-19) Pandemic
    • COVID-19 Market Scenario
    • Demand Supply of Animal Healthcare Products
  5. Europe Animal Healthcare Market, By Animal Type, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Livestock Animals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Bovine
        • Porcine
        • Poultry
        • Others
      • Companion Animals
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
          • Canine
          • Feline
          • Equine
  6. Europe Animal Healthcare Market, By Route of Administration, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Topical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Injectable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Subcutaneous Injections
        • Intramuscular Injections
        • Intravenous Injections
        • Intra-peritoneal Injections
        • Others
  7. Europe Animal Healthcare Market, By Indication, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Infectious Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Pain
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Autoimmune Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  8. Europe Animal Healthcare Market, By Country, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Country, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Country, 2017–2027
    • U.K.
      • Market Size and Forecast, By Animal Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
    • Germany
      • Market Size and Forecast, By Animal Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
    • France
      • Market Size and Forecast, By Animal Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
    • Spain
      • Market Size and Forecast, By Animal Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
    • Russia
      • Market Size and Forecast, By Animal Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
    • Switzerland
      • Market Size and Forecast, By Animal Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
    • Netherlands
      • Market Size and Forecast, By Animal Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
    • Italy
      • Market Size and Forecast, By Animal Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
    • Rest of Europe
      • Market Size and Forecast, By Animal Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • Merck & Co., Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Virbac
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Dechra Pharmaceuticals Plc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Vetoquinol S.A.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Zoetis Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Ceva Santé Animale
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bayer AG
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Elanco
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Evonik Industries AG
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Archer Daniels Midland Company
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
    • Analyst Views
  10. Section
    • Research Methodology
    • About us and Sales Contact

*Browse 38 market data tables and 27 figures on "Europe Animal Healthcare Market” - Forecast to 2027

Frequently Asked Questions

The Europe animal healthcare market size is estimated to be valued at US$ 13,119.7 million in 2020 and is expected to exhibit a CAGR of 4.5% between 2020 and 2027.
Increasing incidence of zoonotic viral pathogens, increasing demand for protein from animal source, and increasing government initiatives to provide improved animal healthcare are bolstering the market growth.
The livestock segment is expected to be the leading animal type segment in the Europe animal healthcare market during the forecast period (2020-2027).
U.K. animal healthcare market is expected to generate highest revenue share during the forecast period.
Key factors hampering growth of the market include stringent regulations for sales and usage of antibiotics, and high cost of animal healthcare services.
Major players operating in the Europe animal healthcare market include Merck & Co., Inc., Virbac, Dechra Pharmaceuticals Plc., Vetoquinol S.A., ., Zoetis Inc., Ceva Santé Animale, Bayer AG, Elanco, Evonik Industries AG, and Archer Daniels Midland Company.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner